Anti-Inflammatory Effects of Combined Budesonide/Formoterol in COPD Exacerbations

By Bathoorn Erik   Liesker Jeroen   Postma Dirkje   Boorsma Martin   Bondesson Eva   Koëter Gerard   Kauffman Henk   van Oosterhout Antoon   Kerstjens Huib  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 5, Iss. 5, 2008-10 ,pp. : 282-290

Informa Healthcare

Access to resources Recommend Favorite

Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety

By Bodzenta-Lukaszyk Anna   Buhl Roland   Balint Beatrix   Lomax Mark   Spooner Kay   Dissanayake Sanjeeva  

Journal of Asthma, Vol. 49, Iss. 10, 2012-12 ,pp. : 1060-1070

Informa Healthcare

Access to resources Recommend Favorite

Early Bronchodilatory Effects of Budesonide/Formoterol pMDI Compared with Fluticasone/Salmeterol DPI and Albuterol pMDI: 2 Randomized Controlled Trials in Adults with Persistent Asthma Previously Treated with Inhaled Corticosteroids

By Hampel Frank   Martin Paula   Mezzanotte William  

Journal of Asthma, Vol. 45, Iss. 4, 2008-05 ,pp. : 265-272

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Patient-Reported Outcomes During Treatment With Adjustable- and Fixed-Dose Budesonide/Formoterol Pressurized Metered-Dose Inhaler Versus Fixed-Dose Fluticasone Propionate/Salmeterol Dry Powder Inhaler in Patients With Asthma

By O'Connor Richard D.   Patrick Donald L.   Parasuraman Bhash   Martin Paula   Goldman Mitchell  

Journal of Asthma, Vol. 47, Iss. 2, 2010-03 ,pp. : 217-223

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β₂-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler

By Berger William E.   Noonan Michael J.  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 447-459

Informa Healthcare

Access to resources Recommend Favorite